Cost-effectiveness of a genetic test for breast cancer risk--letter.

نویسندگان

  • David G Cox
  • Stéphane Ragusa
  • Lionel Pourtau
  • Lionel Perrier
  • Suzette Delaloge
چکیده

David G. Cox, Stéphane Ragusa, Lionel Pourtau, Lionel Perrier, Suzette Delaloge 1 Université de Lyon, Lyon, France 2 Université Lyon 1, ISPB, Lyon, France 3 INSERM U1052, Centre de Recherche en Cancérologie de Lyon, Lyon, France 4 CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, Lyon, France 5 Centre Léon Bérard, Pôle de Recherche Translationnelle, F-69008 Lyon, France 6 Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London UK 7 Statlife, Cancer Campus, Bâtiment M. Tubiana, Institut Gustave Roussy, Villejuif, France 8 University of Paris Sud, Ethics Research Department, Le Kremlin Bicêtre, France 9 Institut Gustave Roussy, Villejuif, France 10 CNRS UMR 5824 GATE Lyon-St. Etienne, Ecully, France 11 Centre Léon Bérard, Department of Cancer, Environment, and Health Economics, Lyon, France 12 Breast Cancer Group and High-Risk Clinic, Institut Gustave Roussy, Villejuif, France

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Rapid Health Technology Assessment of Oncotype DX in Patients with Early-Stage Breast Cancer

Introduction: Breast cancer is the most common cancer in women. Patients are treated with chemotherapy initially, and if not chemically treated, the risk of recurrence of the disease increases yearly. Therefore, methods for identifying patients for whom chemotherapy would be most beneficial are very important. The Oncotype DX test is a prognostic assay that predicts the likelihood of breast can...

متن کامل

Association of Obesity Related Genetic Variants (FTO and MC4R) with Breast Cancer Risk:a population-based case-control study in Iran

Background: The heterogeneous breast cancer is the most common cause of cancer-related mortality. Obesity defined by BMI is known as a major risk factor for breast cancer. Objective: The purpose of this study was to explore the role of obesity related-polymorphisms rs9939609 FTO and rs17782313 MC4R in breast cancer development. Materials and Methods: We obtained matched peripheral blood, serum ...

متن کامل

Cost-effectiveness of a genetic test for breast cancer risk.

Genetic testing of seven single-nucleotide polymorphisms (7SNP) can improve estimates of risk of breast cancer relative to the Gail risk test alone, for the purpose of recommending MRI screening for women at high risk. A simulation of breast cancer and health care processes was used to conduct a virtual trial comparing the use of the 7SNP test with the Gail risk test to categorize patients by r...

متن کامل

Association Between Oncotype DX Recurrence Score and Clinicopathological Variables in Breast Cancer Patients

Introduction: Breast cancer is the most common cancer and the leading cause of cancer-related death in women. Clinicopathological variables are important factors in deciding on breast cancer treatment. This study evaluated the association between the recurrence score generated by the Oncotype DX® 21-gene assay and classic clinicopathological variables. Methods: A single-institution retrospect...

متن کامل

Cost effectiveness of personalized treatment in women with early breast cancer: the application of OncotypeDX and Adjuvant! Online to guide adjuvant chemotherapy in Austria

A Breast Cancer Outcomes model was developed at the ONCOTYROL research center to evaluate personalized test-treatment strategies in Austria. The goal was to evaluate the cost-effectiveness of a new 21-gene assay (ODX) when used in conjunction with the Adjuvant! Online (AO) decision aid to support personalized decisions about use of adjuvant chemotherapy in early-stage breast cancer patients in ...

متن کامل

جهش های ژنتیکی جدید در ژن های اصلی سرطان پستان (BRCA1/BRCA2) در زنان ایرانی مبتلا به سرطان پستان زودرس

Background: Breast cancer is the most common female malignancy and the main cause of death in  mid-aged women. Genetic germ line mutations in BRCAI/BRCA2 in Iranian women with breast or  ovarian cancer have not been yet reported. Materials and methods: Clinical data, family history and blood samples were obtained from 83  females aged less than 45 years with primary breast cancer in order to su...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Cancer prevention research

دوره 7 4  شماره 

صفحات  -

تاریخ انتشار 2014